Elanco Animal Health Incorporated (ELAN) Q2 FY26 Earnings Call

8% organic growth and 20% midpoint EPS growth prompted higher 2026 guidance [24][28][29].

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-05
Length65 minutes
EPS$0.34
EPS consensus$0.27
Revenue$1.4B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q4 FY25

All ELAN earnings ยท Back to ELAN overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.